We can help you move discovery research into an effective innovation pipeline.

Liverpool is a major academic and translational centre for infectious diseases research with over 500 researchers in LSTM and UoL working directly in this field.  We have a successful track record working with industry from discovery through to clinical trials contributing to products currently in clinical development or on the market including drugs, diagnostics, vaccines and insecticides.

Funding the future of Innovative healthcare

Our portfolio of external research grants is worth in excess of £100 million per annum (from funders including industry, MRC, The Wellcome Trust, USAID, DFID, BMGF, NIHR,and the European Union) and covers antimicrobials, diagnostics, drugs, vaccines and vector control products at all stages of the pipeline – from early stage discovery to large scale operational implementation and evaluation.